Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Proposed changes to the Medical Devices Regulations to address future public health...

Health Canada is proposing regulatory amendments to the Medical Devices Regulations (MDR). We're proposing to expand the current provisions under Part 1.1 of the MDR, currently...

USA – AdvaMed calls for changes to FDA’s non-spinal bone fixation device guidance

The medtech lobby group AdvaMed has asked the US Food and Drug Administration (FDA) to make changes to its recent guidance on orthopedic non-spinal...

USA – FDA finalizes guidance for containment system used with power morcellators

The US Food and Drug Administration (FDA) has finalized guidance that lists non-clinical testing information the agency wants from sponsors of tissue containment systems...

USA – MedCon: Consider the device risk management file a ‘living document’

Device manufacturers need to keep their risk documentation up to date throughout the total product life cycle by monitoring production and post-production information, according...

USA – FDA issues draft guidance on decentralized clinical trials

In a newly released draft guidance, the US Food and Drug Administration (FDA) is proposing recommendations on conducting decentralized clinical trials (DCTs) of drugs,...

USA – EPA proposes rules on EtO with implications for medical device sterilization

The US Environmental Protection Agency (EPA) has proposed two much-anticipated rules that would restrict how much ethylene oxide (also referred to as EO or...

USA – FDA draft guidance allows AI/ML devices to evolve without requiring new submissions

The US Food and Drug Administration (FDA) published a draft guidance outlining how sponsors of artificial intelligence and machine learning (AI/ML) products can submit...

NOS PROCHAINES FORMATIONS